Page 16 - Indian Stock Exchanges

AstraZeneca Pharma share price rises 3% on CDSCO nod for Eculizumab

AstraZeneca share rose after it that the company has secured permission to import pharmaceutical formulations of new drug for sale or for distribution in Form CT-20 from CDSCO

Analysts bullish on HDFC Life post Q3 results; Nomura upgrades to 'Buy'

Nomura, which previously downgraded the stock to Neutral in Q2FY25 due to concerns about surrender value impact, slowing growth, and higher valuations, has now upgraded its rating to 'Buy'

Here's why Waaree Technologies share was locked in 5% upper circuit today

Waaree Technologies share price rose after it received an order of 99 sets of Solar off grid combo from a customer engaged in the trading activities

These 2 smallcap stocks hit new highs; zoom up to 82% in two months

Goldiam International has rallied 9% to Rs 569.50 in intraday trade, zooming 82% in 2 months and PGIL has surged 6% to Rs 1,718.05 in intraday trade, soared 71% in two months.

Paytm share rallies 8% as Emkay upgrades to 'Buy' from 'Add', lifts target

The northward movement in the Paytm share price came after domestic brokerage Emkay upgraded the stock to 'Buy' from 'Add'. It also raised the target price to Rs 1,050, from 750 earlier

Market Today: GIFT Nifty; RIL, Infy, Axis Bk Q3; Laxmi Dental IPO allotment

At 6:35 AM, GIFT Nifty futures indicated a gap-up opening for the markets, trading 150 points higher at 23,416

How to trade Nifty Pharma, Metal indices today, Jan 16? Check levels here

The Nifty Pharma Index is witnessing a bearish trend in the near term, with strong support anticipated in the range of 21,825 to 21,700

Jefferies, CLSA, Morgan Stanley retain 'Hold' on HCLTech despite Q3 miss

HCLTech declared a dividend of Rs 18 per share, including a special Rs 6 per share dividend to commemorate 25 years since its public listing, marking its 88th consecutive quarter of dividend payouts

Jindal Stainless races 4% as Nuvama upgrades to 'Buy,' raises target price

The rally in Jindal Stainless shares followed an upgrade by Nuvama Institutional Equities (Nuvama), which raised its rating on the stock to 'Buy' from 'Hold' and set a revised target price of Rs 836

Biocon extends rally, up 6% in 2 days on HSBC, Motilal Oswal 'Buy' upgrade

Notably, Biocon share price has surged about 6 per cent in the last two sessions

Ravi Nathani recommends sell-on-rise strategy for Nifty IT, Auto indices

The Nifty IT Index is exhibiting a clear bearish trend in the near term, prompting traders to adopt a cautious stance

Here's why Waaree Energies share was buzzing in trade on Jan 13; details

Waaree Energies share rose after it entered into a Share Purchase Agreement with Enel Green Power Development for acquisition of Enel Green Power for Rs 792 crore

Afcom Holdings shares hit 5% upper circuit on long-term pact with Etihad

Afcom Holdings shares rose after it announced that it has entered into a long-term contract with Etihad, to operate regular scheduled flights between Chennai-Male sector to move their cargo

Goldman Sachs initiates coverage with 'Neutral' on BSE; share price up 2%

The uptick in the BSE share price came after New York, US-based brokerage Goldman Sachs initiated coverage with 'Neutral' rating for a target price of Rs 5,060

Markets Today: GIFT Nifty; Dec Inflation; HCLTech Q3; Standard Glass IPO

At 6:32 AM, GIFT Nifty futures indicate a gap-down opening for the markets, trading 160 points lower at 23,341

IndusInd Bank down 4% as Goldman Sachs downgrades to 'Neutral', cuts target

The downfall in the IndusInd Bank share price came after reports indicated that the New York-based brokerage Goldman Sachs downgraded the stock to 'Neutral'

Surya Roshni shares pop 5% on securing deal from BPCL for CGD project

The uptick in Surya Roshni share price came after the company announced that it has secured an order of Rs 81.47 crore from Bharat Petroleum Corporation Limited (BPCL)

Ajmera Realty rises 4% on Q3 biz nos., pares gains later on profit booking

The uptick in Ajmera Realty share price came after the company reported its operational numbers for the December quarter of financial year 2025 (Q3FY25)

Swiggy races 6% as Bernstein initiates with 'Outperform'; sees 29% upside

The northward move in the Swiggy share price came after reports suggested that global brokerage Bernstein initiated coverage with 'Outperform' rating on the Swiggy stock, with a target price of Rs 635

HSBC downgrades Indian markets to 'Neutral,' slashes Sensex target for 2025

HSBC has revised its Sensex target for the end of 2025, lowering it to 85,990, from 90,520 earlier